View all newsletters
Receive our newsletter – data, insights and analysis delivered to you
Sponsored by Baxter BioPharma Solutions

Using a Risk-Based Approach to Manufacturing in a Multi-Product Facility

Free White Paper

Using a Risk-Based Approach to Manufacturing in a Multi-Product Facility

By Baxter BioPharma Solutions

Using a Risk-Based Approach to Manufacturing in a Multi-Product Facility

By Baxter BioPharma Solutions
Enter your details to receive the free paper:

Manufacturing in multi-product facilities affords numerous advantages but also presents significant challenges.

At its Halle / Westfalen, Germany, plant, Baxter BioPharma Solutions has implemented a risk-based approach to addressing those challenges, providing customers with the benefits of multiproduct manufacturing.

The biopharmaceutical industry is continually challenged to reduce costs and the time needed to produce advanced drug products. Drug manufacturers are consequently pursuing numerous approaches to achieving gains in efficiency and productivity.

 

NEWSLETTER Sign up Tick the boxes of the newsletters you would like to receive. A weekly roundup of the latest news and analysis, sent every Friday. The pharmaceutical industry's most comprehensive news and information delivered every month.
I consent to GlobalData UK Limited collecting my details provided via this form in accordance with the Privacy Policy
SUBSCRIBED

THANK YOU